Intermittent ADT has QoL advantage in advanced prostate cancer

Researchers say that intermittent androgen deprivation therapy may be preferable to conventional continuous treatment for some men with advanced prostate cancer.
Source: MedWire News - Urology - Category: Urology & Nephrology Source Type: news